Target intelligence / Profile preview

Radiopaque contrast agent

Molecular classification
Other
01

Overview

A radiopaque contrast agent is a substance administered to a patient's body to enhance the visibility of internal anatomical structures during X-ray-based imaging techniques such as radiography, computed tomography (CT), and fluoroscopy. These agents typically contain high atomic number elements—most commonly iodine or, for gastrointestinal imaging, barium sulfate—which absorb X-rays and cause the radiographed area to appear white or opaque. Their primary role is to provide diagnostic contrast by physically blocking or attenuating the passage of X-rays, thereby allowing clinicians to distinguish between different tissues and detect abnormalities. Radiopaque contrast agents do not interact with biological systems as traditional drugs or molecular targets do, and their action is strictly physical. Use of these agents carries risks, including allergic reactions and possible kidney damage, particularly in susceptible individuals. "Radiopaque contrast" is not a molecular or therapeutic target but rather a descriptive term for this broad class of X-ray contrast enhancers.

Other names
Radiographic contrast agentX-ray contrast agentIodinated contrast agent (for iodine-based agents)Barium sulfate (for GI applications)Contrast media
02

Mechanism of action

Physical X-ray absorption

03

Disease associations

Other
04

Safety considerations

Allergic reactions (including anaphylactoid reactions to iodinated agents)Contrast-induced nephropathy (especially in patients with impaired renal function)Extravasation injuries (accidental leakage into adjacent tissue)Other risks: Barium peritonitis (if barium leaks outside the GI tract), pulmonary edema (if certain agents are misused), metallic taste, sensation of warmthSpecial populations: pre-existing renal impairment, prior contrast reactions, asthma, allergies

Beyond the preview

Go deeper on Radiopaque contrast agent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radiopaque contrast agent.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call